Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2017 1
2020 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Lipid metabolism and lung cancer.
Merino Salvador M, Gómez de Cedrón M, Moreno Rubio J, Falagán Martínez S, Sánchez Martínez R, Casado E, Ramírez de Molina A, Sereno M. Merino Salvador M, et al. Crit Rev Oncol Hematol. 2017 Apr;112:31-40. doi: 10.1016/j.critrevonc.2017.02.001. Epub 2017 Feb 13. Crit Rev Oncol Hematol. 2017. PMID: 28325263 Review.
Adjuvant chemotherapy in endometrial cancer.
Gómez-Raposo C, Merino Salvador M, Aguayo Zamora C, Casado Saenz E. Gómez-Raposo C, et al. Among authors: merino salvador m. Cancer Chemother Pharmacol. 2020 Mar;85(3):477-486. doi: 10.1007/s00280-019-04027-6. Epub 2020 Jan 16. Cancer Chemother Pharmacol. 2020. PMID: 31950214 Review.
Immune checkpoint inhibitors in endometrial cancer.
Gómez-Raposo C, Merino Salvador M, Aguayo Zamora C, García de Santiago B, Casado Sáenz E. Gómez-Raposo C, et al. Among authors: merino salvador m. Crit Rev Oncol Hematol. 2021 May;161:103306. doi: 10.1016/j.critrevonc.2021.103306. Epub 2021 Apr 8. Crit Rev Oncol Hematol. 2021. PMID: 33839243 Review.
Oxaliplatin induced-neuropathy in digestive tumors.
Sereno M, Gutiérrez-Gutiérrez G, Gómez-Raposo C, López-Gómez M, Merino-Salvador M, Tébar FZ, Rodriguez-Antona C, Casado E. Sereno M, et al. Among authors: merino salvador m. Crit Rev Oncol Hematol. 2014 Jan;89(1):166-78. doi: 10.1016/j.critrevonc.2013.08.009. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24029604 Review.
Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy.
Gómez-Raposo C, Andreu M, Suárez-García I, Esteban MI, Carballo M, Sereno-Moyano MF, Vázquez Osorio JL, Heras J, Zambrana Tévar F, Pelayo E, López-Gómez M, García de Santiago C, Merino Salvador M, Casado E. Gómez-Raposo C, et al. Among authors: merino salvador m. Clin Transl Oncol. 2012 Jun;14(6):486-8. doi: 10.1007/s12094-012-0828-9. Clin Transl Oncol. 2012. PMID: 22634539